Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CTO-1681 by CytoAgents for Cytokine Release Syndrome (Cytokine Storm): Likelihood of Approval
CTO-1681 is under clinical development by CytoAgents and currently in Phase II for Cytokine Release Syndrome (Cytokine Storm). According to...